Congenital Tricuspid Valve Malformation in Dogs and Cats: A Retrospective Study of 50 Cases
WSAVA 2002 Congress
*Carlos C., Tran-Cong D., Tessier D., Pouchelon J. L., Chetboul V.
*Unité de Cardiologie. Ecole National de Vétérinaire d'Alfort
Maisons-Alfort Cédex, FR
c.carlos.s@terra.es

OBJECTIVES

Congenital tricuspid valve malformation (CTVM) includes apical displacement of the tricuspid valve annulus (Ebstein's malformation, EM), and a variety of right atrioventricular valve abnormalities classified as tricuspid valve dysplasia (TD), i.e., abnormal leaflets, underdevelopment of papillary muscles or chordae tendinae, and adherence of the septal leaflet to the interventricular septum. CTVM usually results in tricuspid regurgitation which may lead to right atrial and ventricular enlargement, and then to right-sided heart failure. The objectives of this retrospective study were first to document the predisposition parameters for CTVM in small animal medicine; secondly, to assess the clinical signs and echo-Doppler findings in a population of dogs and cats with a diagnosis of CTVM and to determine their influence on survival time.

MATERIALS

Dogs and cats were recruited between March 1995 and March 2002 from the Department of Cardiology of the National Veterinary School of Alfort (France). All animals underwent a complete clinical examination. The inclusion criteria included the presence of tricuspid regurgitation (confirmed with Doppler mode) associated with one or more of the following: focal or diffuse thickening of tricuspid valve leaflets, hypoplasia of right chordae tendinae, abnormal form of right papillary muscles, incomplete separation of valve components from the ventricular wall. The distributions of breeds and genders in the studied population with CTVM and in the overall hospital population were compared using odds ratios.

RESULTS

50 cases were diagnosed with CTVM, 36 dogs (53% males, 47% females) and 14 cats (64% males, 36% females). 24 dogs and 14 cats showed TD and 12 dogs, EM. Concurrent congenital cardiac abnormalities, most often mitral dysplasia, were identified in 77% dogs and in all cats. 62% of cases were diagnosed in animals younger than 1 year old. Comparison with the small animal hospital population (85250 animals: 50637 dogs and 34613 cats) revealed no gender predisposition for CTVM. Conversely, Boxers were predisposed for TD (17% of cases) and Labrador retrievers for EM (67% of cases). Purebred cats (50%) showed predisposition to TD, especially Chartreux (28% of cases). No functional symptom was observed in 41% of cases. Intensity of heart murmur was not correlated to CTVM gravity. Higher mortality was found for animals with EM (33%, mean age at death: 26±2 months), however EM was identified in dogs as old as 7 years of age.

CONCLUSION

This study demonstrates that EM and TD have specific characteristics: not only echocardiographic abnormalities, but also breed and species predisposition, symptomatology, and sometimes evolution may be very different according to the tricuspid malformation. Our results also show that animals with CTVM may live with few symptoms for several years, even if right heart enlargement is already present at the time of diagnosis.

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

C. Carlos
Unité de Cardiologie. Ecole Nationale Vétérinaire d'Alfort
7, Av Charles de Gaulle
Maisons-Alfort Cédex, 94704 FR

V. Chetboul
Unité de Cardiologie. Ecole National de Vétérinaire d'Alfort

D. Tessier
U. de cardiologie - E.N. V. d'Alfort
7 av du général de Gaulle
Maisons-Alfort Cédex, France 94704 FR

J. L. Pouchelon
Unité de Cardiologie. Ecole National de Vétérinaire d'Alfort

D. Tran-Cong
Unité de Cardiologie. Ecole National de Vétérinaire d'Alfort


MAIN : : Tricuspid Valve Malformation
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27